Ride Health And Uber Health Partner To Simplify Patients’ Path To Medical Appointments
Companies aim to lower healthcare costs by combining multiple transportation options, ensuring all patients get the care they need to ensure good health  

See more here


Relmada Therapeutics Strengthens Financial Operations with Addition of Maged Shenouda as Chief Financial Officer

See more here


Ride Health Raises $6.2 Million to Coordinate the Medical Transportation Ecosystem
Company delivers first real-time ride coordination platform to improve access to care and patients’ ride experience  

See more here


Relmada Therapeutics Strengthens Board of Directors with Appointment of Life Sciences Industry Veterans, Eric Schmidt, Ph.D., and John Glasspool

See more here


iView Announces First Patient Treated in Phase 2 Clinical Trial Program Evaluating IVIEW-1201 in Patients with Acute Adenoviral Conjunctivitis

See more here


Relmada Therapeutics Announces Closing of $115 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

See more here


Harvard Pilgrim Health Care And Ride Health Collaborate To Provide Health Care-Related Transportation For Medicare Members In Two States

See more here


CARB-X funds VenatoRx Pharmaceuticals to support the development of a new class of oral antibiotics to treat multi-drug-resistant gonorrhea
Funding represents 51st CARB-X Award, and 2nd CARB-X Award for VenatoRx 

See more here